Advancing consumer insights: efficient sentiment analysis-based recommendation system using multi-criteria decision making with a game theoretic approach
Annals of Operations Research · vol. 356 (1) · 539-558
المخرجات
Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.
3,288 output
Annals of Operations Research · vol. 356 (1) · 539-558
Food Chemistry · vol. 499 · 147325-147325
Journal of Molecular Structure · vol. 1354 · 144717-144717
Future Medicinal Chemistry · vol. 17 (24) · 2959-2973
Aims This study aimed to synthesize and evaluate novel furan derivatives as potential anticancer agents targeting colon cancer through VEGFR-2 inhibition and apoptosis induction.Materials and methods The cytotoxic activity of the synthesized compounds was assessed against human fibroblast (HSF) and colon cancer cell lines (HCT-116, Caco-2, and HT-29) using the MTT assay. VEGFR-2 inhibitory activity was determined in vitro, and immunocytochemistry was employed to evaluate VEGFR-2 expression. Apoptosis, cell cycle arrest, and migration inhibition were analyzed in Caco-2 cells. Molecular docking, molecular dynamics (MD) simulations, Density Functional Theory (DFT), and ADMET analyses were conducted to assess binding affinity, stability, and safety profiles.Results Compound 6 exhibited potent cytotoxicity against HT-29 (IC50 = 22.39 μM) and strong VEGFR-2 inhibition (IC50 = 0.28 ± 0.42 μM), comparable to sorafenib. It suppressed VEGFR-2 expression, induced G2/M cell cycle arrest, and promoted early and late apoptosis in 97% of treated Caco-2 cells. Upregulation of Bax and caspase-3, along with downregulation of Bcl-2, confirmed intrinsic apoptotic activation. Computational analyses supported compound 6’s stability and drug-likeness.Conclusions Compound 6 is a promising lead furan derivative with potent, selective anticancer activity against colon cancer via VEGFR-2 inhibition and apoptosis induction. Further, in vivo evaluation is warranted.
Food Science & Nutrition · vol. 13 (11) · e71128-e71128
Georgi. It has been recognized as an active phytochemical with specific therapeutic potential and significant pharmacological effects, especially in cancer research. Nevertheless, increasing preclinical data both in vitro and in vivo demonstrate its effectiveness against a broad spectrum of cancers, including breast, ovarian, lung, gastric, colorectal, prostate, renal, glioblastoma, and hematological types. Wogonin exerts its anticancer effects through a complex mechanism that involves the induction of programmed cell death (apoptosis), autophagic modulation, and cell cycle arrest. It also suppresses angiogenesis of tumors, epithelial-mesenchymal transition (EMT), invasion, metastasis, and multidrug resistance effects. The effects are supported by the compound's ability to regulate a variety of oncogenic and tumor-suppressive signaling pathways, particularly PI3K/Akt, STAT3, NF-kB, MAPK, AMPK, and Wnt/beta-catenin. It modulates apoptosis-related proteins (Bax, Bcl-2, PARP, caspases) and transcription factors. Wogonin has been shown to enhance the antitumor effects of established chemotherapeutic agents, and it works synergistically with these drugs in multiple cancer models, with the added benefits of reduced systemic toxicity. Nevertheless, it has poor oral bioavailability and water solubility, which limits its clinical application. Recent advances in nanocarriers and liposomal delivery systems show promise in overcoming pharmacokinetic challenges. This review consolidates available pharmacological, mechanistic, and pharmacokinetic evidence of wogonin, highlights its potential in combination therapies, and identifies research gaps and formulation strategies necessary for advancing this candidate towards clinical development as a novel anticancer agent.
Journal of Molecular Structure · vol. 1352 · 144397-144397
Luminescence · vol. 40 (9) · e70301-e70301
In the current study, the triazole antifungal terconazole (TRZ) was determined using a novel, extremely sensitive, and environmentally friendly spectrofluorimetric approach. A methanolic solution of TRZ exhibited strong native fluorescence at 373 nm when excited at 241 nm. With a correlation coefficient of 0.9999, a straight-lined calibration curve was produced over the concentration range of 5.0-600.0 ng/mL. With quantification and detection limits of 4.64 and 1.53 ng/mL, respectively, the developed approach showed ultrasensitivity reaching the nanogram scale. Due to its great sensitivity, the method could successfully estimate TRZ in human plasma samples with low %RSD values and high recoveries (98.31-101.66). The method was also effectively used to analyze the TRZ in its vaginal suppositories and creams without interference from existing excipients. With satisfactory results, the method's applicability was expanded to the analysis of TRZ in environmental water samples. Two distinct green metrics, AGSA and MoGAPI, were applied to validate the approach's greenness profile and eco-friendliness. The method's applicability and economic feasibility were also verified using the BAGI tool. According to ICHQ2 (R2) criteria, the proposed approach underwent complete validation. This work introduced the first spectrofluorimetric method for TRZ analysis, enabling its usage in pharmacological, biological, and environmental monitoring.
Medical Oncology · vol. 42 (10) · 452-452
ChemistrySelect · vol. 10 (25)
Abstract In this study, a series of nicotinamide‐dihydrothiadiazole hybrids were synthesized and evaluated for their anticancer potential through VEGFR‐2 inhibition. Among the synthesized compounds, 7c demonstrated a very promising VEGFR‐2 inhibitory activity (IC₅₀ = 0.098 ± 0.05 µM), comparable to the reference drug sorafenib (IC₅₀ = 0.1 ± 0.05 µM). In vitro cytotoxicity studies revealed that 7c exhibited significant anticancer activity against MDA‐MB‐231 (IC₅₀ = 6.92 ± 0.4 µM) and MCF‐7 (IC₅₀ = 9.18 ± 0.7 µM) breast cancer cell lines, with minimal toxicity toward normal cells (WI‐38 and WISH). Mechanistic studies indicated that 7c induces G0/G1 phase arrest and apoptosis, as evidenced by increased late apoptotic populations (45.58%) and upregulation of caspase‐3, Bax, and a significant reduction in Bcl‐2. Computational analyses, encompassing molecular docking and 200 ns molecular dynamics (MD) simulations, demonstrated the stable interaction of 7c with VEGFR‐2, highlighting its excellent binding affinity. Additionally, Swiss ADMET predictions highlighted the favorable pharmacokinetic and safety profiles of 7c , including non‐mutagenic and noncarcinogenic properties, moderate absorption, and high plasma protein binding (>90%). These findings establish nicotinamid‐dihydrothiadiazole hybrids, particularly 7c , as promising VEGFR‐2 inhibitors with dual mechanisms of angiogenesis inhibition and apoptosis induction.
Annals of Medicine · vol. 57 (1) · 2516697-2516697
INTRODUCTION: Several severe disorders, such as inherited diseases (e.g. cystic fibrosis and beta thalassemia), genetic diseases (e.g. malignant tumors and diabetes), and infectious diseases (e.g. HIV) are pose significant challenges to human health. BACKGROUND: Over the past few decades, researchers have been working on gene therapies, and currently, terrible dreams have come true. To date, the Food and Drug Administration (FDA) has approved multiple gene therapies such as Kynamro for familial hypercholesterolaemia, Exondys51 for duchenne muscular dystrophy, Spinraza for spinal muscular atrophy, etc., rest for cancer, infectious diseases, and rare diseases. DISCUSSION: The authors have summarized recent advances in gene therapy, its background, molecular basis (e.g. viral and non-viral vectors), gene-editing techniques (e.g. CRISPR/Cas9, TALEN, ZFN), and its foremost applications in severe disorders, such as cancer, monogenic disorders (e.g. spinal muscular atrophy), polygenic disorders (e.g. autism), neurogenic disorders (e.g. Parkinson disease and Alzheimer's disease), and infectious diseases (e.g. HIV). CHALLENGES: In addition, we explored the major challenges faced by gene therapies during targeted delivery, immunogenicity, efficacy, and safety. CONCLUSION: have paved the foundation for applications of gene therapies. Additionally, advances in enhancing the immune system that would certainly lower the healthcare costs. This review highlights the translatory potential of gene therapy in revolutionizing the treatment landscape for severe disorders.
Naunyn-Schmiedeberg s Archives of Pharmacology · vol. 398 (12) · 17609-17632
PLoS ONE · vol. 20 (6) · e0323573-e0323573
BACKGROUND: Repeated sprint ability (RSA) is essential for football performance, especially in maintaining high-intensity efforts throughout a match. Repeated sprint training (RST) improves both aerobic and anaerobic capacities; however, its effects on players in different positional roles remain underexplored, particularly with regard to tailored conditioning protocols. OBJECTIVE: This study assessed the impact of on-field RST on physical performance metrics, including aerobic capacity (VO₂max), sprint speed (10m DASH), vertical jump height (VJH), and power output, with a focus on positional differences among forwards, defenders, and goalkeepers. METHODS: Forty male football players (aged 18-25 years) were purposively sampled and matched by position before allocation into experimental (RST) and control groups. The experimental group completed a structured four-week RST program, while the control group continued routine football training involving technical, tactical, and endurance drills. Pre- and post-intervention assessments included the Cooper Test (aerobic capacity), VO₂max, VJH, power output, and 10m DASH. RESULTS: After 4 weeks of RST, significant mprovements were observed in the experimental group. VO2max increased by 4.4 ml/kg/min (95% CI: 2.9 to 6.0; p < 0.001, d = 1.31), and 10m sprint time decreased by 0.32 seconds (95% CI: -0.45 to -0.19; p < 0.001, d = 1.36) in forwards. VJH improved significantly (p < 0.001) among defenders (Δ = 3.44 cm, 95% CI: 1.76 to 5.12, d = 1.06), while power improvements were most notable in defenders (Δ = 43.44W, 95% CI: 28.62 to 58.26, d = 1.00). Goalkeepers showed modest, non-significant improvements. Significant positional differences were identified for VJH and power output (p < 0.001). CONCLUSION: RST significantly enhanced physical performance metrics, particularly for forwards and defenders. The findings emphasize the importance of positional specificity in training programs to optimize football performance.
PLoS ONE · vol. 20 (6) · e0322313-e0322313
Secure data transmission is critical to cloud-based electronic healthcare (e-healthcare) systems. Upon delving into the literature, it becomes clear that several security mechanisms have been developed to ensure the security of exchanged information across patients, physicians, and the cloud server, but they do not resist vulnerabilities such as man-in-the-middle, side-channel, and session key hijacking attacks. These vulnerabilities can seriously compromise the integrity of exchanged medical records. In light of this, the article proposes a cloud-assisted key agreement protocol for the e-healthcare system to enable secure authentication for patient monitoring, enhancing mutual authentication of the participating entities and creating protected session keys for secure open-channel communication. The proposed methodology employs robust and lightweight procedures, including SHA-256 and Elliptic Curve Cryptography (ECC), while considering the challenges of implementing strong security protocols in healthcare systems, such as the need for high performance and low energy consumption. The proof of correctness and robustness of the proposed protocol has been analyzed through the Real-Or-Random (RoR) model, ProVerif verification toolkit, and pragmatic illustration, while the efficiency and efficacy were checked by measuring computation, communication, storage costs, and energy consumption. The result obtained from the security analysis demonstrated that the proposed protocol resisting man-in-the-middle, replay, DoS, traceability/tracking, desynchronization, impersonation, and side channel attacks offers key secrecy, confidentiality, integrity, and authorization. In contrast, the result depicted from the performance analysis section shows that the proposed protocol is 46.99% better in communication, 96.46% in computation, and 53.69% in energy consumption, which is inaugurating its superiority over its competitors. Hence, it is recommended for practical implementation in the real-world cloud-based e-healthcare scenario.
Scientific Reports · vol. 15 (1) · 17299-17299
Diabetes mellitus (DM) is a growing public health concern globally, particularly in Saudi Arabia, where increasing prevalence is associated with significant morbidity. This study aimed to assess the prevalence of diabetes-related complications among patients in Riyadh and examine the impact of sociodemographic factors, comorbidities, and lifestyle habits on these complications. A cross-sectional study was conducted with 980 diabetic patients attending health centers in Riyadh from March to April 2023. Data were collected via a validated bilingual questionnaire that captured sociodemographic information, diabetes-related variables, comorbid conditions, lifestyle habits, and complications. Statistical analyses, including descriptive statistics, chi-square tests, and binary regression, were performed via SPSS to identify significant associations. A p-value less than 0.05 was considered significant for all comparisons. Among the participants (980), 38% (378) reported diabetes-related complications, primarily neuropathy (30%), retinopathy (25%), and cardiovascular diseases (20%). Complications were significantly associated with older age (p < 0.001) and longer diabetes duration (more than 5 years; p < 0.001). Individuals with hypertension, hyperlipidemia, heart disease, kidney disease, and obesity had significantly higher complication rates than those without these conditions (p < 0.05). The most pronounced association was observed in participants with heart disease (85% vs. 15%; RR = 1.506), highlighting the need for better management of these comorbidities. Consuming fruits and vegetables, milk, and regular exercise were inversely associated with the risk of complications (p < 0.05). Conversely, sugary drinks, white bread, sheesha/vaping, and inadequate sleep were linked to increased risk (p < 0.05), highlighting the protective role of healthy dietary and lifestyle habits. This study highlights the impact of sociodemographic factors and lifestyle choices-such as age, education, family history, comorbidities, and poor diet-on diabetes complications. While early detection and lifestyle interventions are vital, a cautious approach is needed when applying these findings to other regions, given differences in socioeconomic circumstances.
Journal of Molecular Structure · vol. 1341 · 142586-142586